Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions

NCT00375427 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer With Bone Metastasis

Interventions

DRUG: Zoledronic acid

Sponsor

Novartis Pharmaceuticals